A Comparative Study of the Profile of Cognitive Impairment and Associated Factors among Subsets of Human Immunodeficiency Virus Patients in a Special Human Immunodeficiency Virus Clinic in South-East Nigeria.
Olisaeloka Ginikachi Ebeogu, Paul Osemeke Nwani, Harriet Chinwe Nwadimkpa, Obiora Daniel Anaje, Nnamdi Joseph Morah, Ifeoma Adaigwe Amaechi, Stephen Okorafor Kalu, Linda Ifunanya Eze, Azuoma Lasbrey Asomugha, Maduaburochukwu Cosmas Nwosu, Ogunniyi Adesola
{"title":"A Comparative Study of the Profile of Cognitive Impairment and Associated Factors among Subsets of Human Immunodeficiency Virus Patients in a Special Human Immunodeficiency Virus Clinic in South-East Nigeria.","authors":"Olisaeloka Ginikachi Ebeogu, Paul Osemeke Nwani, Harriet Chinwe Nwadimkpa, Obiora Daniel Anaje, Nnamdi Joseph Morah, Ifeoma Adaigwe Amaechi, Stephen Okorafor Kalu, Linda Ifunanya Eze, Azuoma Lasbrey Asomugha, Maduaburochukwu Cosmas Nwosu, Ogunniyi Adesola","doi":"10.4103/aam.aam_36_25","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>The human immunodeficiency virus (HIV) is a neurotropic virus with several neurological manifestations including cognitive impairment.</p><p><strong>Aims: </strong>This study aimed to determine and compare the frequency of cognitive impairment and associated factors among subsets of HIV-positive patients and matched controls using neuropsychological test battery.</p><p><strong>Settings and design: </strong>This was a comparative cross-sectional descriptive study conducted in a Southeastern Nigerian Special HIV clinic.</p><p><strong>Subjects and methods: </strong>Two subsets of HIV patients; the combination antiretroviral therapy (CART) experienced patients and the CART naïve patients and matched HIV negative subjects were surveyed using the World Health Organization/University of California, Los Angeles neuropsychological test battery.</p><p><strong>Statistical analysis: </strong>Statistical Package for the Social Science version 20.0 was used.</p><p><strong>Results: </strong>The overall frequency of neurocognitive impairment was 76.1% (mild 44.6% and moderate-to-severe cognitive 31.5%). Although there was no statistically significant difference in the percentages of CART naïve patients (76.3%; n = 29/38) and CART-exposed (75.9%, n = 41/54) that had cognitive impairment, severe cognitive impairment was more among the CART naïve patients (44.4%; n = 24/54) and mild cognitive impairment more among CART-exposed (63.1%; n = 24/38). CART-exposed patients had better scores in most of the subtests of the battery compared to CART-naïve patients but the observed difference was not statistically significant. The observed relationship between cognitive impairment and age, sex, or level of education was also not statistically significant.</p><p><strong>Conclusion: </strong>HIV-associated neurocognitive impairment is still common in HIV patients and treatment with ART may reduce its severity.</p>","PeriodicalId":7938,"journal":{"name":"Annals of African Medicine","volume":" ","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of African Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/aam.aam_36_25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Context: The human immunodeficiency virus (HIV) is a neurotropic virus with several neurological manifestations including cognitive impairment.
Aims: This study aimed to determine and compare the frequency of cognitive impairment and associated factors among subsets of HIV-positive patients and matched controls using neuropsychological test battery.
Settings and design: This was a comparative cross-sectional descriptive study conducted in a Southeastern Nigerian Special HIV clinic.
Subjects and methods: Two subsets of HIV patients; the combination antiretroviral therapy (CART) experienced patients and the CART naïve patients and matched HIV negative subjects were surveyed using the World Health Organization/University of California, Los Angeles neuropsychological test battery.
Statistical analysis: Statistical Package for the Social Science version 20.0 was used.
Results: The overall frequency of neurocognitive impairment was 76.1% (mild 44.6% and moderate-to-severe cognitive 31.5%). Although there was no statistically significant difference in the percentages of CART naïve patients (76.3%; n = 29/38) and CART-exposed (75.9%, n = 41/54) that had cognitive impairment, severe cognitive impairment was more among the CART naïve patients (44.4%; n = 24/54) and mild cognitive impairment more among CART-exposed (63.1%; n = 24/38). CART-exposed patients had better scores in most of the subtests of the battery compared to CART-naïve patients but the observed difference was not statistically significant. The observed relationship between cognitive impairment and age, sex, or level of education was also not statistically significant.
Conclusion: HIV-associated neurocognitive impairment is still common in HIV patients and treatment with ART may reduce its severity.
期刊介绍:
The Annals of African Medicine is published by the Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria and the Annals of African Medicine Society. The Journal is intended to serve as a medium for the publication of research findings in the broad field of Medicine in Africa and other developing countries, and elsewhere which have relevance to Africa. It will serve as a source of information on the state of the art of Medicine in Africa, for continuing education for doctors in Africa and other developing countries, and also for the publication of meetings and conferences. The journal will publish articles I any field of Medicine and other fields which have relevance or implications for Medicine.